Esperion Therapeutics Inc. has granted 77,650 restricted stock units (RSUs) to 23 new employees under its 2017 Inducement Equity Incentive Plan. Each RSU will vest 25 percent on the one-year anniversary of the recipient's vesting commencement date, with the remaining 75 percent vesting in twelve equal quarterly installments thereafter, contingent on continued employment.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Esperion Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9569884-en) on November 06, 2025, and is solely responsible for the information contained therein.